Cargando…
Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
Osteosarcoma is the most common primary malignant bone tumour in children and adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure. Introduction of combination chemotherapy in the 1970s, however, dramatically increased overall survival rates from 20% to approximat...
Autores principales: | Lilienthal, Ingrid, Herold, Nikolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555161/ https://www.ncbi.nlm.nih.gov/pubmed/32961800 http://dx.doi.org/10.3390/ijms21186885 |
Ejemplares similares
-
Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma
por: Shaikh, Atik Badshah, et al.
Publicado: (2016) -
Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies
por: Rathore, Richa, et al.
Publicado: (2021) -
Efficacy of an anti-cancer strategy targeting SET in canine
osteosarcoma
por: TSUJI, Shunya, et al.
Publicado: (2019) -
Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives
por: Almansa-Gómez, Sergio, et al.
Publicado: (2023) -
Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
por: Hattinger, Claudia Maria, et al.
Publicado: (2021)